Xihui Ying

517 total citations
18 papers, 397 citations indexed

About

Xihui Ying is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Xihui Ying has authored 18 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 6 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Xihui Ying's work include Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Xihui Ying is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Xihui Ying collaborates with scholars based in China. Xihui Ying's co-authors include Jianfei Tu, Jiansong Ji, Fazong Wu, Dengke Zhang, Yahui Ding, Hai Zou, Minjiang Chen, Zhongwei Zhao, Jingjing Song and Zhongzhi Jia and has published in prestigious journals such as Scientific Reports, Medicine and Oncotarget.

In The Last Decade

Xihui Ying

18 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xihui Ying China 9 188 102 99 95 75 18 397
Hitomi Suzuki Japan 9 106 0.6× 111 1.1× 65 0.7× 99 1.0× 68 0.9× 43 459
Jianxing Zeng China 11 131 0.7× 132 1.3× 44 0.4× 44 0.5× 89 1.2× 37 372
Frank Seebach United States 9 64 0.3× 166 1.6× 57 0.6× 92 1.0× 59 0.8× 37 407
Howard Liu Australia 13 78 0.4× 202 2.0× 60 0.6× 198 2.1× 81 1.1× 43 555
Adam Duckworth United Kingdom 7 145 0.8× 203 2.0× 25 0.3× 77 0.8× 54 0.7× 18 380
Wan Ling Tan Singapore 8 144 0.8× 149 1.5× 53 0.5× 152 1.6× 15 0.2× 22 407
Noritaka Wakui Japan 10 247 1.3× 55 0.5× 51 0.5× 56 0.6× 21 0.3× 70 398
Lizhu Han China 9 43 0.2× 145 1.4× 47 0.5× 62 0.7× 61 0.8× 27 358
Ru-Hai Zou China 9 176 0.9× 65 0.6× 30 0.3× 59 0.6× 23 0.3× 15 361

Countries citing papers authored by Xihui Ying

Since Specialization
Citations

This map shows the geographic impact of Xihui Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xihui Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xihui Ying more than expected).

Fields of papers citing papers by Xihui Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xihui Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xihui Ying. The network helps show where Xihui Ying may publish in the future.

Co-authorship network of co-authors of Xihui Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Xihui Ying. A scholar is included among the top collaborators of Xihui Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xihui Ying. Xihui Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ying, Xihui, Jiahao Wu, Chunli Kong, et al.. (2024). Glycerophospholipid-driven lipid metabolic reprogramming as a common key mechanism in the progression of human primary hepatocellular carcinoma and cholangiocarcinoma. Lipids in Health and Disease. 23(1). 326–326. 9 indexed citations
2.
Kong, Chunli, Xiaofeng Jin, Weiyue Chen, et al.. (2023). Machine Learning Classifier for Preoperative Prediction of Early Recurrence After Bronchial Arterial Chemoembolization Treatment in Lung Cancer Patients. Academic Radiology. 30(12). 2880–2893. 8 indexed citations
3.
Liu, Wei‐Wen, et al.. (2022). Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort. BMJ Open. 12(4). e049789–e049789. 4 indexed citations
4.
Kong, Chunli, Zhongwei Zhao, Weiyue Chen, et al.. (2021). Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE. European Radiology. 31(10). 7500–7511. 97 indexed citations
5.
Li, Ling, Jiali Liu, Xiujuan Li, et al.. (2021). The Preventive Value of Acupoint Sensitization for Patients with Stable Angina Pectoris: A Randomized, Double-Blind, Positive-Controlled, Multicentre Trial. Evidence-based Complementary and Alternative Medicine. 2021. 1–9. 11 indexed citations
6.
7.
8.
9.
10.
Ying, Xihui, Jianfei Tu, Wenxian Wang, et al.. (2019). <p><em>FGFR2-BICC1</em>: A Subtype Of <em>FGFR2</em> Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib</p>. OncoTargets and Therapy. Volume 12. 9303–9307. 8 indexed citations
11.
Zhao, Zhongwei, Xiaoxi Fan, Lili Yang, et al.. (2019). Recognition of Lung Adenocarcinoma-specific Gene Pairs Based on Genetic Algorithm and Establishment of a Deep Learning Prediction Model. Combinatorial Chemistry & High Throughput Screening. 22(4). 256–265. 1 indexed citations
12.
Zhang, Heying, et al.. (2019). Multiple metachronous rare primary malignant tumors: A case report. Thoracic Cancer. 10(10). 2050–2053. 2 indexed citations
13.
Tu, Jianfei, Xihui Ying, Dengke Zhang, et al.. (2017). High expression of angiogenic factor AGGF1 is an independent prognostic factor for hepatocellular carcinoma. Oncotarget. 8(67). 111623–111630. 11 indexed citations
14.
Tu, Jianfei, Zhongzhi Jia, Xihui Ying, et al.. (2016). The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma. Medicine. 95(49). e5606–e5606. 60 indexed citations
15.
Tu, Jianfei, Yahui Ding, Xihui Ying, et al.. (2016). Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival. Scientific Reports. 6(1). 35056–35056. 104 indexed citations
16.
Song, Jingjing, Zhongwei Zhao, Xiaoxi Fan, et al.. (2016). Shikonin potentiates the effect of arsenic trioxide against human hepatocellular carcinomain vitroandin vivo. Oncotarget. 7(43). 70504–70515. 30 indexed citations
17.
Tu, Jianfei, Jiansong Ji, Fazong Wu, et al.. (2014). Effectiveness of Combined 131I-chTNT and Radiofrequency Ablation Therapy in Treating Advanced Hepatocellular Carcinoma. Cell Biochemistry and Biophysics. 71(2). 777–784. 11 indexed citations
18.
Tu, Jianfei, Jiansong Ji, Fazong Wu, et al.. (2014). [Efficacies of ¹³¹I-chTNT plus radiofrequency ablation for the treatment of advanced hepatocellular carcinoma].. PubMed. 94(45). 3586–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitomi Suzuki Breakdown of academic impact, for papers by Jianxing Zeng Breakdown of academic impact, for papers by Frank Seebach Breakdown of academic impact, for papers by Howard Liu Breakdown of academic impact, for papers by Adam Duckworth Breakdown of academic impact, for papers by Wan Ling Tan Breakdown of academic impact, for papers by Noritaka Wakui Breakdown of academic impact, for papers by Lizhu Han Breakdown of academic impact, for papers by Ru-Hai Zou
Rankless by CCL
2026